crizanlizumab
Crizanlizumab is a RESTRICTED medication. Use is restricted to patients >16 years of age when outside of a study protocol.
Crizanlizumab is a RESTRICTED medication. Use is restricted to patients >16 years of age when outside of a study protocol.